Canada markets close in 1 hour 8 minutes

Edgewise Therapeutics, Inc. (EWTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.11-0.20 (-1.16%)
At close: 04:00PM EDT
17.11 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.60B
Enterprise Value 1.07B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.99
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.22

Trading Information

Stock Price History

Beta (5Y Monthly) 0.16
52-Week Change 375.49%
S&P500 52-Week Change 326.14%
52 Week High 321.60
52 Week Low 35.12
50-Day Moving Average 317.35
200-Day Moving Average 311.74

Share Statistics

Avg Vol (3 month) 3717.91k
Avg Vol (10 day) 3632.9k
Shares Outstanding 593.4M
Implied Shares Outstanding 694.49M
Float 852.33M
% Held by Insiders 10.47%
% Held by Institutions 1109.01%
Shares Short (Apr 30, 2024) 46.52M
Short Ratio (Apr 30, 2024) 412
Short % of Float (Apr 30, 2024) 410.28%
Short % of Shares Outstanding (Apr 30, 2024) 46.98%
Shares Short (prior month Mar 28, 2024) 45.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.14%
Return on Equity (ttm)-24.51%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -121.58M
Net Income Avi to Common (ttm)-105.85M
Diluted EPS (ttm)-1.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)532.76M
Total Cash Per Share (mrq)5.7
Total Debt (mrq)5.25M
Total Debt/Equity (mrq)0.98%
Current Ratio (mrq)37.08
Book Value Per Share (mrq)5.74

Cash Flow Statement

Operating Cash Flow (ttm)-97.72M
Levered Free Cash Flow (ttm)-59.75M